TRAMP-C2 cells represent a prototypic murine androgen-dependent prostate cancer cell line derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model which express cytokeratin, E-cadherin, and androgen receptor but has wild type p53 [41]. The gene discussed is TP53; the disease is prostate carcinoma.